The analysis of tumor xenografts for miR-143 levels revealed indeed a >40% downregulation of miR-143 upon treatment with PEI/siHER2 or upon PEI/siRNA-mediated double knockdown of HER2 and HER3 (Figure 3D). The gene discussed is ERBB2; the disease is neoplasm.